About Us

Authored by Dr. John G. Bartlett, Dr. Joel E. Gallant and Paul Pham, Pharm.D., all of The Johns Hopkins University Division of Infectious Diseases, with support from numerous professionals in HIV care, this book has been updated and republished yearly since 1988 and is now also published in South Africa, Russia, and will soon be published in Ethiopia.

• Dr. John G. Bartlett Author

  John G. Bartlett, M.D., is a Professor of Medicine in the Division of The Johns Hopkins University School of Medicine, Baltimore, Maryland and is the lead author of the Medical Management of HIV. Dr. Bartlett is an internationally renowned authority on AIDS and other infectious diseases. For 26 years, he led The Johns Hopkins School of Medicine's worldwide efforts to understand, prevent and treat AIDS. Dr. Bartlett has authored over 500 articles and reviews, more than 280 book chapters, and over 60 editions of 18 books. He has served on editorial boards for 19 medical journals.

• Dr. Joel E. Gallant Author

  Joel E. Gallant, M.D., M.P.H. is Professor of Medicine in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine in Baltimore, Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and Associate Director of the Johns Hopkins AIDS Service. He has conducted dozens of domestic and international clinical trials on the treatment and prevention of HIV infection. He is the editor-in-chief of the Johns Hopkins HIV Guide and the author of 100 Questions and Answers about HIV and AIDS, a book for lay readers.

• Paul Pham, Pharm. D. Author

  Paul A. Pham, Pharm.D., is a Research Associate on the faculty with the Division of Infectious Diseases at Johns Hopkins University School of Medicine. Paul Pham received his undergraduate degree from University of Maryland in 1993 and earned his doctor of pharmacy at the University of Mississippi in 2000. In 2000, he joined the faculty at Johns Hopkins University, School of Medicine. His major interests are HIV/AIDS clinical care and antiretroviral drug interactions. Dr. Pham also has a joint appointment with University of Maryland School of Pharmacy and serves on the CDC/NIH/IDSA opportunistic infection guidelines committee.

• GileadSponsor

  Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and experimental drug candidate, we seek to improve the care of patients suffering from life-threatening diseases around the world. Gilead's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular/metabolic and respiratory conditions.

  Our portfolio of 14 marketed products includes a number of category firsts, including the only complete treatment regimens for HIV infection available in a once-daily single pill – Atripla® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), approved in 2006, and Complera® (emtricitabine/rilpivirine/tenofovir disoproxil fumarate), approved in 2011. www.Gilead.com

• TheraSim, Inc.Sponsor

  As a leader in virtual patient simulation, TheraSim is impacting clinical practice from all angles; allied health, nursing, and physicians can all benefit from the consequence-free, highly interactive environment of simulation on the TheraSim 360 Platform.

  Empowering students with a self-paced educational interaction tailored to their performance, TheraSim virtual patient simulation can improve clinical performance, outcomes, and professional confidence. www.TheraSim.com

• Knowledge Source Solutions Publisher

  Knowledge Source Solutions(KSS) specializes in text, guides and online media for the medical field. By expanding the use of mixed media, KSS brings the latest updates in modern medicine to health care professionals worldwide. www.KnowledgeSourceSolutions.com